Mersana Therapeutics, Inc. Current Liabilities
Mersana Therapeutics, Inc. had Current Liabilities of $43.27 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-11-14
- 2025-09-30: Liabilities, Current $43.27M.
- 2025-06-30: Liabilities, Current $59.34M.
- 2025-03-31: Liabilities, Current $58.16M.
- 2024-12-31: Liabilities, Current $62.46M.
| Period end | Liabilities, Current |
|---|---|
| 2025-09-30 | $43.27M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $59.34M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $58.16M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $62.46M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $68.30M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $62.18M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $53.41M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $63.64M 10-K · filed 2025-03-03 |
| 2023-09-30 | $67.93M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $74.92M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $83.40M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $91.53M 10-K · filed 2024-02-28 |
| 2022-09-30 | $88.79M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $71.47M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $56.46M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $47.52M 10-K · filed 2023-02-28 |
| 2021-09-30 | $44.02M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $40.47M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $34.92M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $30.00M 10-K · filed 2022-02-28 |
| 2020-09-30 | $21.07M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $22.42M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $17.49M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $24.07M 10-K · filed 2021-02-26 |
| 2019-09-30 | $22.38M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $23.92M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $22.59M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $69.42M 10-K · filed 2020-02-28 |
| 2018-09-30 | $31.44M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $31.88M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $29.34M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $31.88M 10-K · filed 2019-03-08 |
| 2017-09-30 | $24.51M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $31.43M 10-Q · filed 2017-08-11 |
| 2016-12-31 | $28.39M 10-K · filed 2018-03-28 |